BIOSTAR PHARM-B (02563) has announced that Dr. Meng Songdong has tendered his resignation from his positions as an independent non-executive director, chairman of the remuneration and assessment committee, and member of the audit committee, effective April 29, 2026, due to requirements from his primary employer. The board of directors has resolved to propose the appointment of Dr. Zhu Xiaodong as an independent non-executive director for the second board of directors. His term will conclude at the end of the second board's tenure, pending approval by shareholders through relevant resolutions at the company's annual general meeting.